SQZ Biotechnologies Co Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
SQZ Biotechnologies Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q3 2023.
  • SQZ Biotechnologies Co Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$23.6M, a 4.4% decline year-over-year.
  • SQZ Biotechnologies Co Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$71.6M, a 7.84% increase year-over-year.
  • SQZ Biotechnologies Co annual Net Income (Loss) Attributable to Parent for 2022 was -$79.5M, a 15.6% decline from 2021.
  • SQZ Biotechnologies Co annual Net Income (Loss) Attributable to Parent for 2021 was -$68.7M, a 36.1% decline from 2020.
  • SQZ Biotechnologies Co annual Net Income (Loss) Attributable to Parent for 2020 was -$50.5M, a 56.9% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$71.6M -$23.6M -$996K -4.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$70.6M -$16.8M +$5.47M +24.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$76.1M -$17.7M +$3.35M +15.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$79.5M -$13.5M -$1.73M -14.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-22
Q3 2022 -$77.7M -$22.6M -$193K -0.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$77.5M -$22.2M -$3.17M -16.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$74.4M -$21M -$5.64M -36.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$68.7M -$11.8M +$5.78M +32.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$74.5M -$22.5M -$10.1M -81.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$64.4M -$19.1M -$9.08M -91% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$55.3M -$15.4M -$4.82M -45.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$50.5M -$17.6M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$12.4M -$4.47M -56.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.99M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$10.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$7.88M Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.